| Code | 6989E | ||||||||||
| MA number | 58/0194/24-S | ||||||||||
| Product Form: | tbl mod 60x160 mg/1,5 mg (blis.OPA/Al/PVC//Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 30.07.2024 |
| Validity: | 30.07.2029 |
| PIL: |
PIL_Vabinxo 160-1,5 mg_tbl mod_03_2025.pdf
|
| SPC: |
SPC_Vabinxo 160-1,5 mg_tbl mod_03_2025.pdf
|
| Safety feature | Yes |
| Data update: | 31.07.2024 |
